Evidence map›Paper›PMID 26252390›Full record

ArticlePLoS pathogens2015

A Novel Virus Causes Scale Drop Disease in Lates calcarifer.

Ad de Groof, Lars Guelen, Martin Deijs, Yorick van der Wal, Masato Miyata, Kah Sing Ng, Lotte van Grinsven, Bartjan Simmelink, Yvonne Biermann, Luc Grisez and 5 more

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed
6.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 126 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Genomic analysis ofbioRxiv : the preprint server for biology · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Molecular epidemiology ofVeterinary world · 2023
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 2 institutions in 1 country.

Ad de GroofMSD Animal Health / Intervet International bv., Department Discovery & Technology, Boxmeer, The Netherlands.
Lars GuelenMSD Animal Health / Intervet International bv., Department Discovery & Technology, Boxmeer, The Netherlands.
Martin DeijsLaboratory of Experimental Virology, Department of Medical Microbiology, Center for Infection and Immunity Amsterdam (CINIMA), Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
Yorick van der WalMSD Animal Health / Intervet International bv., Department Discovery & Technology, Boxmeer, The Netherlands.
Masato MiyataMSD Animal Health Innovation Pte Ltd, Singapore.
Kah Sing NgMSD Animal Health Innovation Pte Ltd, Singapore.
Lotte van GrinsvenMSD Animal Health / Intervet International bv., Department Discovery & Technology, Boxmeer, The Netherlands.
Bartjan SimmelinkMSD Animal Health / Intervet International bv., Department Discovery & Technology, Boxmeer, The Netherlands.
Yvonne BiermannMSD Animal Health / Intervet International bv., Department Discovery & Technology, Boxmeer, The Netherlands.
Luc GrisezMSD Animal Health / Intervet International bv., Department Discovery & Technology, Boxmeer, The Netherlands.
Jan van LentLaboratory of Virology and Wageningen Electron Microscopy Centre, Wageningen University, Wageningen, The Netherlands.
Anthony de RondeLaboratory of Experimental Virology, Department of Medical Microbiology, Center for Infection and Immunity Amsterdam (CINIMA), Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
Siow Foong ChangMSD Animal Health Innovation Pte Ltd, Singapore.
Carla SchrierMSD Animal Health / Intervet International bv., Department Discovery & Technology, Boxmeer, The Netherlands.
Lia van der HoekLaboratory of Experimental Virology, Department of Medical Microbiology, Center for Infection and Immunity Amsterdam (CINIMA), Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
University of Amsterdam · NLWageningen University & Research · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

From 1992 onwards, outbreaks of a previously unknown illness have been reported in Asian seabass (Lates calcarifer) kept in maricultures in Southeast Asia. The most striking symptom of this emerging disease is the loss of scales. It was referred to as scale drop syndrome, but the etiology remained enigmatic. By using a next-generation virus discovery technique, VIDISCA-454, sequences of an unknown virus were detected in serum of diseased fish. The near complete genome sequence of the virus was determined, which shows a unique genome organization, and low levels of identity to known members of the Iridoviridae. Based on homology of a series of putatively encoded proteins, the virus is a novel member of the Megalocytivirus genus of the Iridoviridae family. The virus was isolated and propagated in cell culture, where it caused a cytopathogenic effect in infected Asian seabass kidney and brain cells. Electron microscopy revealed icosahedral virions of about 140 nm, characteristic for the Iridoviridae. In vitro cultured virus induced scale drop syndrome in Asian seabass in vivo and the virus could be reisolated from these infected fish. These findings show that the virus is the causative agent for the scale drop syndrome, as each of Koch's postulates is fulfilled. We have named the virus Scale Drop Disease Virus. Vaccines prepared from BEI- and formalin inactivated virus, as well as from E. coli produced major capsid protein provide efficacious protection against scale drop disease.

Indexed as

IridoviridaeAnimalsBassFish DiseasesPhylogenyPolymerase Chain Reaction

Identifiers

PMID26252390
PMCPMC4529248
OpenAlexW1946386342

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.